News & Articles

SelectScience will be attending the AACC Annual Meeting in Chicago, USA, to interview leading scientists and report on the latest technologies

The first chemically-defined, animal component-free cell culture medium for natural killer (NK) cells

Learn how a lab in the US is using cell culture methods to enhance the effectiveness of virus-like particles (VLPs) as novel vaccines against filoviruses

ALS Environmental announces that it is now able to analyze samples for cryptosporidium and giardia at its Wakefield laboratory

An international collaboration between the University of Bath and Universidad de los Andes has developed an integrated device for testing a water source

This year’s research prize awarded by Eppendorf AG goes to Switzerland

To be in with a chance of winning a $500 Amazon voucher, cast your vote by July 23

SelectScience brings you scientific and technical takeaways from the 2018 AACR Annual Meeting

Which new product, instrument or consumable has made the most difference to your clinical lab or point-of-care practice? Nominate now for a chance to win a $500/£400/450€ Amazon voucher

The new system aims to deliver fast, accurate results through near native-state cellular characterization, precise flagging and a 93% first-pass throughput

How a researcher at UC San Diego is elucidating the role of microglial dysfunction in brain trauma and disorders

During the American Association for Cancer Research 2018 Annual Meeting, SelectScience recognized cutting-edge products and technologies advancing life sciences research

Five Prime Therapeutics and Personal Genome Diagnostics collaborate to develop new diagnostic assay for gastric and gastrointestinal cancers

Discover 10 wonderful webinars popular with scientists across the globe in 2017 — and watch them on demand

Ultrasensitive Simoa technology to advance research into tumor-derived exosomes at the University of Pittsburgh Cancer Institute

Ralph McDade explains the importance of using ultra-sensitive immunoassays from Quanterix

Bonnie Howell, Executive Director at Merck, discusses the use of ultrasensitive Quanterix technology to develop novel therapies for HIV and shares her hopes for a future world, free of the disease

Henrik Zetterberg discusses the use of ultrasensitive biomarker assays from Quanterix for Alzheimer’s research